Investor Relations
Press, quotes, SEC filings, alerts, more.
COVID-19
Launching ARTIVeda™ for COVID-19 in India.
Pipeline
Cancer and viral infection treatment information.
EdgePoint AI
Core cloud-computer AI platform.
Most recent news and events
Oncotelic Happenings
IRB Barcelona
TGF-β drives immune evasion in genetically reconstituted colon cancer metastasis. Learn more >
MedRxiV
Targeting TGF-b pathway with COVID-19 Drug Candidate ARTIVeda/PulmoHeal Accelerates Recovery from Mild-Moderate COVID-19. Learn more >
NUTRA Ingredients-Asia
Artemisinin for COVID-19: Indian and US firms launch clinically tested supplement after ayurvedic regulatory approval. Learn more >
CGTN America
Saran Saund, Chief Business Officer, and General Manager of the AI division, of Mateon-Oncotelic Therapeutics, talked about how India is using technology to fight COVID-19. Watch the interview on Youtube HERE.
Empowered Patient Podcast
Virtual Webinar
Ayurveda, Artemisia, and Covid-19
December 16, 2020 7AM PST – 10AM EST – 8:30PM IST
Featuring Global Experts in Ayurveda and Pharmacology. Learn more >
Zacks Research
POSITIVE EARLY RESULTS FOR ARTIVEDATM IN TREATING COVID-19. Learn more >
Oncotelic + Windlas
Oncotelic and Windlas Biotech ready to launch ARTIVeda™ in India to address the COVID pandemic. Learn more >